C. Aguirre-portolès, W. Bird, A. Hyman, M. Cañ-amero, P. De-castro et al., Tpx2 Controls Spindle Integrity, Genome Stability, and Tumor Development, Cancer Research, vol.72, issue.6, pp.1518-1528, 2012.
DOI : 10.1158/0008-5472.CAN-11-1971

I. Pérez-de-castro and M. Malumbres, Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2, Genes & Cancer, vol.3, issue.11-12, pp.721-730, 2012.
DOI : 10.1177/1947601912473306

G. Neumayer, C. Belzil, O. Gruss, and M. Nguyen, TPX2: of spindle assembly, DNA damage response, and cancer, Cellular and Molecular Life Sciences, vol.21, issue.9, pp.3027-3074
DOI : 10.1007/s00018-014-1582-7

H. Chang, J. Wang, Y. Tian, J. Xu, and X. Gou, The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer, Oncology Reports, vol.27, pp.1353-1359, 2012.
DOI : 10.3892/or.2012.1668

A. Adach, A. Ellert-miklaszewska, and B. Kaminska, Molecular Characterization of STAT Signaling in Inflammation and Tumorigenesis, Methods Mol Biol, vol.512, pp.265-278, 2009.
DOI : 10.1007/978-1-60327-530-9_14

L. Pedranzini, A. Leitch, and J. Bromberg, Stat3 is required for the development of skin cancer, Journal of Clinical Investigation, vol.114, issue.5, pp.619-622, 2004.
DOI : 10.1172/JCI22800

D. Frank, STAT3 as a central mediator of neoplastic cellular transformation, Cancer Letters, vol.251, issue.2, pp.199-210, 2007.
DOI : 10.1016/j.canlet.2006.10.017

H. Sellier, A. Rébillard, C. Guette, B. Barré, and O. Coqueret, How should we define STAT3 as an oncogene and as a potential target for therapy?, JAK-STAT, vol.65, issue.3, p.24716, 2013.
DOI : 10.1073/pnas.1201232109

E. Agostinelli, F. Belli, A. Molinari, M. Condello, and P. Palmigiani, Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): Sensitization by heat and MDL 72527, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1763, issue.10, pp.1040-50, 2006.
DOI : 10.1016/j.bbamcr.2006.07.014

M. Motti, D. Califano, G. Baldassarre, A. Celetti, and F. Merolla, Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas, Carcinogenesis, vol.26, issue.6, pp.1021-1055, 2005.
DOI : 10.1093/carcin/bgi050

J. Turkson, D. Ryan, J. Kim, Y. Zhang, and Z. Chen, Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation, Journal of Biological Chemistry, vol.276, issue.48, pp.45443-45455, 2001.
DOI : 10.1074/jbc.M107527200

M. Rojas, J. Donahue, Z. Tan, and Y. Lin, Genetic engineering of proteins with cell membrane permeability, Nature Biotechnology, vol.89, issue.4, pp.370-375, 1998.
DOI : 10.1016/0378-1119(88)90005-4

M. Eufemi, S. Coppari, F. Altieri, C. Grillo, and A. Ferraro, ERp57 is present in STAT3???DNA complexes, Biochemical and Biophysical Research Communications, vol.323, issue.4, pp.1306-1312, 2004.
DOI : 10.1016/j.bbrc.2004.09.009

S. Chichiarelli, S. Coppari, C. Turano, M. Eufemi, and F. Altieri, Immunoprecipitation of DNA???Protein Complexes Cross-Linked by cis-Diamminedichloroplatinum, Analytical Biochemistry, vol.302, issue.2, pp.224-229, 2002.
DOI : 10.1006/abio.2001.5543

. Wittmannt, H. Boleti, C. Antony, E. Karsenti, and I. Vernos, Localization of the Kinesin-like Protein Xklp2 to Spindle Poles Requires a Leucine Zipper, a Microtubule-associated Protein, and Dynein, The Journal of Cell Biology, vol.268, issue.3, pp.673-85, 1998.
DOI : 10.1073/pnas.89.10.4462

M. Lemaire, A. Schwartz, A. Rahmouni, and M. Leng, Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA., Proceedings of the National Academy of Sciences, vol.88, issue.5, pp.1982-1985, 1991.
DOI : 10.1073/pnas.88.5.1982

C. Yu, J. Ortaldo, R. Curiel, H. Young, and S. Anderson, Role of a STAT binding site in the regulation of the human perforin promoter, J Immunol, vol.162, pp.2785-2790, 1999.

W. Meyer, P. Reichenbach, U. Schindler, E. Soldaini, and M. Nabholz, Interaction of STAT5 Dimers on Two Low Affinity Binding Sites Mediates Interleukin 2 (IL-2) Stimulation of IL-2 Receptor ?? Gene Transcription, Journal of Biological Chemistry, vol.272, issue.50, pp.31821-31828, 1997.
DOI : 10.1074/jbc.272.50.31821

R. Satow, M. Shitashige, Y. Kanai, F. Takeshita, and H. Ojima, Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma, Clinical Cancer Research, vol.16, issue.9, pp.2518-2528, 2010.
DOI : 10.1158/1078-0432.CCR-09-2214

L. Zhang, H. Huang, L. Deng, M. Chu, and L. Xu, TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide, Toxicology, vol.252, issue.1-3, pp.49-55, 2008.
DOI : 10.1016/j.tox.2008.07.059

P. Vainio, J. Mpindi, P. Kohonen, V. Fey, and T. Mirtti, High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer, PLoS ONE, vol.21, issue.6, p.39801, 2012.
DOI : 10.1371/journal.pone.0039801.s008

M. Ramakrishna, L. Williams, S. Boyle, J. Bearfoot, and A. Sridhar, Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis, PLoS ONE, vol.37, issue.4, p.9983, 2010.
DOI : 10.1371/journal.pone.0009983.s010

S. Warner, B. Stephens, S. Nwokenkwo, G. Hostetter, and A. Sugeng, Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells, Clinical Cancer Research, vol.15, issue.21, pp.6519-6528, 2009.
DOI : 10.1158/1078-0432.CCR-09-0077

P. Wei, N. Zhang, Y. Xu, X. Li, and D. Shi, TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer, Journal of Translational Medicine, vol.11, issue.1, p.313, 2013.
DOI : 10.1186/1479-5876-11-313